<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19760" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Common Variable Immunodeficiency</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pescador Ruschel</surname>
            <given-names>Marco A.</given-names>
          </name>
          <aff>Medical Center Santa Rita</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vaqar</surname>
            <given-names>Sarosh</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Marco Pescador Ruschel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sarosh Vaqar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19760.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Common variable immunodeficiency is a disorder characterized by defective B cell function leading to impaired immunoglobulin production. It can present with heterogeneous clinical manifestations such as recurrent infections, chronic lung disease, autoimmune disorders, gastrointestinal disease, or increased risk of malignancy. While some researchers have identified some genetic defect, the fundamental cause of CVID has been challenging to determine.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the pathophysiology of common variable immunodeficiency disease.</p></list-item><list-item><p>Review the evaluation of common variable immunodeficiency disease, especially to avoid a delayed diagnosis.</p></list-item><list-item><p>Describe the treatment and management options available for common variable immunodeficiency disease.</p></list-item><list-item><p>Outline interprofessional team strategies for improving care coordination and communication to improve short-term and long-term outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19760&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19760">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-19760.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Common variable immunodeficiency disorder (CVID) is diverse, both in its clinical presentation and in the types of deficiency. It is a primary humoral immunodeficiency disorder characterized by reduced serum levels of immunoglobulin G (IgG) and immunoglobulin A (IgA) or immunoglobulin M (IgM), recurrent sinopulmonary infections, autoimmune disorders, granulomatous diseases, enhanced risk of malignancy, and impaired antibody response despite the adequate number of B cells.<xref ref-type="bibr" rid="article-19760.r1">[1]</xref><xref ref-type="bibr" rid="article-19760.r2">[2]</xref></p>
        <p>It is the most frequent symptomatic primary immunodeficiency disorder worldwide.<xref ref-type="bibr" rid="article-19760.r2">[2]</xref><xref ref-type="bibr" rid="article-19760.r3">[3]</xref> Rather than a disease, it is a collection of hypogammaglobulinemia syndromes resulting from various genetic defects (almost all of them are specific molecular defects with as yet an unknown cause),<xref ref-type="bibr" rid="article-19760.r1">[1]</xref> named &#x0201c;variable&#x0201d; because of its heterogeneous clinical manifestations.<xref ref-type="bibr" rid="article-19760.r4">[4]</xref></p>
      </sec>
      <sec id="article-19760.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The main cause of CVID remains unknown despite more than four decades of investigation. It is known that environmental and genetic factors may be involved: approximately, 20% of CVID patients have a first-degree family member with a selective IgA deficiency; while the specific environmental factors are unclear, the genetic influence in CVID is believed to cause an intrinsic B cell defect (CD19-deficiency by mutations in <italic toggle="yes">CD19</italic>; 16p11.2), an intrinsic T cell defect (ICOS-deficiency by mutations in <italic toggle="yes">ICOS</italic>; 2q33), and mutations in TNF receptors (TACI-deficiency or BAFFR- deficiency by mutations in <italic toggle="yes">TNFRSF13B</italic>&#x000a0;and&#x000a0;<italic toggle="yes">TNFRSF13C</italic>&#x000a0;respectively; 17p11.2 and 22q13.1-q13.31). Other monogenic defects reported include MSH5, CD81, and CD20 deficiencies; however, CVID can be present without a known genetic defect.<xref ref-type="bibr" rid="article-19760.r5">[5]</xref><xref ref-type="bibr" rid="article-19760.r6">[6]</xref><xref ref-type="bibr" rid="article-19760.r7">[7]</xref><xref ref-type="bibr" rid="article-19760.r8">[8]</xref></p>
        <p>There is no observable, clear pattern of inheritance. Different modes of inheritance, such as autosomal dominant with variable penetrance, autosomal recessive, and X-linked forms, have been reported.<xref ref-type="bibr" rid="article-19760.r9">[9]</xref></p>
      </sec>
      <sec id="article-19760.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>CVID affects approximately 1 of 25000 individuals, with a higher prevalence in northern Europe.<xref ref-type="bibr" rid="article-19760.r10">[10]</xref><xref ref-type="bibr" rid="article-19760.r1">[1]</xref><xref ref-type="bibr" rid="article-19760.r11">[11]</xref> It is typically most diagnosed after puberty, being the majority between 20 and 45 years of age.<xref ref-type="bibr" rid="article-19760.r1">[1]</xref><xref ref-type="bibr" rid="article-19760.r11">[11]</xref><xref ref-type="bibr" rid="article-19760.r4">[4]</xref> It does not show any predilection for race or gender.</p>
      </sec>
      <sec id="article-19760.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The clinical variability of CVID suggests that multiple immunoregulatory defects can result in the final common pathway of hypogammaglobulinemia.<xref ref-type="bibr" rid="article-19760.r1">[1]</xref></p>
        <p>Reports exist of numerous immune-system abnormalities, the most common of which is defective antibody formation. As a consequence, humoral and cell-mediated lymphocytic responses are affected, and some patients may have a defect in the T-cell ability to help B cells, and/or B-cell response to T-cell help<xref ref-type="bibr" rid="article-19760.r12">[12]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>B Cells abnormalities: </bold>The number of B cells is normal in the majority of patients, but many of them have reduced percentages of isotype-switched memory B cells capable of producing immunoglobin isotypes that are critical toward antibody response recall. The abnormalities that appear to occur in the bone marrow include aberrant gene rearrangement, decreased V gene replacements, reduced diversity of the na&#x000ef;ve B cell repertoire, impaired somatic hypermutation, and abnormal expansion of unmutated B cell clones.<xref ref-type="bibr" rid="article-19760.r13">[13]</xref>
<list list-type="bullet"><list-item><p><bold>Toll-like receptor signaling: </bold>B cell maturation is defective, and the action of toll-like receptors 7 and 9 (TLR7 and TLR9) becomes impaired because of a yet unknown mechanism. Defective signaling of TLR7 and TLR9 in B cells and plasmacytoid dendritic cells, along with deficient IFN-a, impairs B cell functions and prevents TLR-mediated augmentation of humoral immunity in vivo.<xref ref-type="bibr" rid="article-19760.r14">[14]</xref><xref ref-type="bibr" rid="article-19760.r15">[15]</xref> The binding of viral RNA to TLR7 or bacterial DNA to TLR9 leads to B cell activation, cytokine secretion, proliferation, and survival; in CVID, the loss of these stimuli functions may contribute to the B cell defects mentioned.<xref ref-type="bibr" rid="article-19760.r16">[16]</xref><xref ref-type="bibr" rid="article-19760.r17">[17]</xref></p></list-item><list-item><p><bold>Memory B cells:</bold> determining the number of isotype-switched memory B cells is of utmost interest because it provides information about the immaturity of the B cell, relates to the numbers of plasma cells in the bone marrow, and gives information about the possible clinical outcomes.<xref ref-type="bibr" rid="article-19760.r18">[18]</xref> Various studies tried to classify CVID patients based on numbers of isotype-switched memory B cells<xref ref-type="bibr" rid="article-19760.r19">[19]</xref><xref ref-type="bibr" rid="article-19760.r20">[20]</xref><xref ref-type="bibr" rid="article-19760.r21">[21]</xref><xref ref-type="bibr" rid="article-19760.r22">[22]</xref><xref ref-type="bibr" rid="article-19760.r23">[23]</xref>:
<list list-type="bullet"><list-item><p>Patients that switched CD27+IgM-IgD- memory B cells had a higher prevalence of splenomegaly and autoimmune cytopenias. This proposed a fast and reliable new classification for CVID patients with flow cytometric quantification of class-switched memory and immature B cells.</p></list-item><list-item><p>Certain disorders were more prevalent in patients with the lowest count of memory B cells (splenomegaly, lymphoid proliferation, granulomatous disease).</p></list-item><list-item><p>Lower levels of IgM memory B cells were associated with chronic pulmonary disease (bronchiectasis).</p></list-item><list-item><p>Research has determined that the percentages of switched memory B cells changed in some patients over time. Based on these findings, the suggestion is that immunologic characteristics have to be evaluated several times after diagnosis.<xref ref-type="bibr" rid="article-19760.r24">[24]</xref></p></list-item></list>
</p></list-item><list-item><p>Decreased T lymphocyte proliferation to mitogens and antigens,<xref ref-type="bibr" rid="article-19760.r1">[1]</xref> reduced T regulatory cells,<xref ref-type="bibr" rid="article-19760.r25">[25]</xref> T cell receptor excision circles that suggest thymic dysregulation,<xref ref-type="bibr" rid="article-19760.r26">[26]</xref> defective T cell receptor signal transduction.</p></list-item><list-item><p>Decrease in CD4+ cell count or increase in CD8+ cell count, altering the CD4/CD8 ratio.<xref ref-type="bibr" rid="article-19760.r27">[27]</xref> Increase in CD26 and CD30 levels (the last ones associated with splenomegaly and malignancy)<xref ref-type="bibr" rid="article-19760.r28">[28]</xref>.</p></list-item><list-item><p>The minor capacity of dendritic cells to secrete interleukin-12.<xref ref-type="bibr" rid="article-19760.r29">[29]</xref></p></list-item><list-item><p>A drop of plasma cells in the gastrointestinal tract and bone marrow.<xref ref-type="bibr" rid="article-19760.r18">[18]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19760.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Chapel et al. have delineated five clinical phenotypes for CVID. Around 80% of their patients had only one of these phenotypes, and 12.6% had criteria for two<xref ref-type="bibr" rid="article-19760.r30">[30]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Uncomplicated (patients usually suffer only infections)</p>
          </list-item>
          <list-item>
            <p>Autoimmunity</p>
          </list-item>
          <list-item>
            <p>Polyclonal lymphocytic infiltration (this includes lymphoid interstitial pneumonitis, unexplained granulomas, unexplained hepatomegaly and/or splenomegaly, and lymphadenopathy)</p>
          </list-item>
          <list-item>
            <p>Enteropathy (biopsy-proven lymphocytic infiltration in lamina propria and interepithelial mucous with villous atrophy)</p>
          </list-item>
          <list-item>
            <p>Lymphoid malignancy</p>
          </list-item>
        </list>
        <p>In any patient with newly diagnosed CVID, two complications have to be considered when assessing the clinical presentation: infectious and non-infectious.</p>
        <p>Patients may suffer the following clinical manifestations at disease onset or throughout life<xref ref-type="bibr" rid="article-19760.r31">[31]</xref><xref ref-type="bibr" rid="article-19760.r32">[32]</xref><xref ref-type="bibr" rid="article-19760.r33">[33]</xref><xref ref-type="bibr" rid="article-19760.r34">[34]</xref><xref ref-type="bibr" rid="article-19760.r35">[35]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Infections</bold>: common organisms like <italic toggle="yes">Haemophilus influenzae</italic>, <italic toggle="yes">Streptococcus</italic>, <italic toggle="yes">Moraxella catarrhalis</italic>, and <italic toggle="yes">Staphylococcus aureus</italic>; and uncommon organisms like <italic toggle="yes">Pneumocystis jirovecii</italic> and <italic toggle="yes">Mycoplasma pneumoniae</italic>:
<list list-type="bullet"><list-item><p>Sinopulmonary infections that can be recurrent and result in bronchiectasis: pneumonia, bronchitis, sinusitis</p></list-item><list-item><p>Otitis</p></list-item><list-item><p>Conjunctivitis</p></list-item><list-item><p>Septic arthritis</p></list-item><list-item><p>Bacterial meningitis</p></list-item><list-item><p>Sepsis</p></list-item><list-item><p>Cutaneous infections</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Lung Disease</bold>
<list list-type="bullet"><list-item><p>Obstructive lung disease, generally because of bronchiectasis (resulting in chronic productive cough and dyspnea, especially in flares)</p></list-item><list-item><p>Restrictive lung disease: normally due to diffuse interstitial lung disease or organizing pneumonia</p></list-item><list-item><p>Primary malignancy (lymphoma) or metastatic gastric carcinoma</p></list-item><list-item><p>Granulomatous disease: manifested as parenchymal nodules and/or ground glass abnormalities</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Autoimmune disorders</bold> (hematologic disorders are the most common form of autoimmunity, with a prevalence of around 20%)<xref ref-type="bibr" rid="article-19760.r36">[36]</xref>:</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Immune thrombocytopenia (10 to 12%)</p>
              </list-item>
              <list-item>
                <p>Coombs-positive autoimmune hemolytic anemia (5 to 7%)</p>
              </list-item>
              <list-item>
                <p>Evans syndrome</p>
              </list-item>
              <list-item>
                <p>Others:
<list list-type="bullet"><list-item><p>Rheumatoid arthritis: 1% to 10% of patients - usually, with negative antinuclear antibodies or rheumatoid factor due to lack of antibodies production.<xref ref-type="bibr" rid="article-19760.r37">[37]</xref></p></list-item><list-item><p>Systemic lupus erythematosus (SLE): a very uncommon finding (less than 1% of patients) but with a curiously predisposal to clinical remission due to loss of B cells or functional antibodies in almost 70% of patients.<xref ref-type="bibr" rid="article-19760.r38">[38]</xref> On the other hand, suggesting more than one mechanism involved between these two associations, there are reports of SLE exacerbations after the development of hypogammaglobulinemia.</p></list-item><list-item><p>Sicca syndrome, Sjogren&#x02019;s syndrome, autoimmune thyroiditis, vitiligo</p></list-item></list>
</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p><bold>Gastrointestinal (GI) infections and other GI disorders</bold>
<list list-type="bullet"><list-item><p>Persistent diarrhea and malabsorption caused by giardiasis, <italic toggle="yes">Clostridium difficile</italic> infection, bacterial enterocolitis, CMV (cytomegalovirus) colitis, <italic toggle="yes">Helicobacter pylori</italic> infection</p></list-item><list-item><p>Severe diarrhea caused by other infections and autoimmunity (inflammatory colitis)</p></list-item><list-item><p>Inflammatory bowel-like disease, sprue-like illness, pernicious anemia (10% of patients),<xref ref-type="bibr" rid="article-19760.r39">[39]</xref> protein-losing enteropathy</p></list-item><list-item><p>Malignancies (the risk of gastric carcinoma is almost 50 times greater in patients with CVID)</p></list-item><list-item><p>Liver disease</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Dermatologic manifestations<xref ref-type="bibr" rid="article-19760.r40">[40]</xref></bold>
<list list-type="bullet"><list-item><p>Alopecia areata or alopecia universalis</p></list-item><list-item><p>Atopic dermatitis</p></list-item><list-item><p>Cutaneous vasculitis (including polyarteritis nodosa)</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Physical examination may be normal in these patients. However, there could be signs and symptoms of chronic illness like<xref ref-type="bibr" rid="article-19760.r41">[41]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Nasal congestion due to chronic sinusitis.</p>
          </list-item>
          <list-item>
            <p>Scars in the tympanic membranes due to recurrent otitis</p>
          </list-item>
          <list-item>
            <p>Weight loss, nocturnal fever, and sweats (B symptoms) due to lymphoid malignancy</p>
          </list-item>
          <list-item>
            <p>Digital clubbing, chronic productive cough, and dyspnea due to chronic pulmonary disease</p>
          </list-item>
          <list-item>
            <p>Lymphadenopathy, splenomegaly, arthritis, conjunctivitis, oral thrush, etc.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19760.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>If the patient&#x02019;s history and physical examination raise a concern about a possible diagnosis of CVID, the evaluation must begin with the laboratory measurement of immunoglobulin levels, demonstration of impaired vaccination response, and exclusion of other abnormalities. The following summarizes some diagnostic procedures according to systems<xref ref-type="bibr" rid="article-19760.r42">[42]</xref>:</p>
        <p>
<bold>Laboratory Tests</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Blood counts (every 3 to 6 months; especially along with autoimmune cytopenia)</p>
          </list-item>
          <list-item>
            <p>Coombs test in case of new anemia (on-demand)</p>
          </list-item>
          <list-item>
            <p>Bone marrow biopsy + beta-2-microglobulin &#x000a0;in case of suspicion of lymphoma or myelodysplasia (on-demand at diagnosis or during follow-up)</p>
          </list-item>
          <list-item>
            <p>Plasma IgG, IgA, IgM (at diagnosis and every 6 months in patients with IVIG replacement; every 1 to 3 months in patients with SCIG replacement)</p>
          </list-item>
          <list-item>
            <p>Flow cytometry for CD3, CD4, CD8, CD19, CD56 lymphocyte subsets (initially and in case of suspicion of a combined immunodeficiency) and T/B cell evaluation</p>
          </list-item>
          <list-item>
            <p>Vaccination responses: tetanus, diphtheria, hepatitis, pneumococcal (at diagnosis)</p>
          </list-item>
          <list-item>
            <p>Sputum: determine pathogens and resistance to antibiotics (on-demand and every 6 to 12 months in case of bronchiectasis)</p>
          </list-item>
          <list-item>
            <p>Sinus simple computed tomography (on-demand)</p>
          </list-item>
        </list>
        <p>
<bold>Lungs</bold>
</p>
        <p>Evaluation of pulmonary disease is essential. There are no international consensus guidelines about pulmonary disease screening. However, there are some recommendations based on clinical experience cited in some publications (European Respiratory Review, Archives of Disease in Childhood, Clinical and Experimental Immunology)<xref ref-type="bibr" rid="article-19760.r43">[43]</xref><xref ref-type="bibr" rid="article-19760.r44">[44]</xref><xref ref-type="bibr" rid="article-19760.r45">[45]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Patients should have a regular evaluation for pulmonary symptoms and characteristics of sputum (color and volume)</p>
          </list-item>
          <list-item>
            <p>Lung function with spirometry, CO diffusion test, and blood gases must be monitored every 6 or 12 months because of its proven decline over time, even in asymptomatic patients; and repeated after every flare or bronchiectasis</p>
          </list-item>
          <list-item>
            <p>Lung volume to assess restrictive disease is for patients who have an intolerance to exercise or who show diffuse parenchymal lung disease on imaging</p>
          </list-item>
          <list-item>
            <p>A chest radiograph is mandatory in all patients that complain about new symptoms</p>
          </list-item>
          <list-item>
            <p>High-resolution computed tomography (HRCT) is recommended in all patients as the initial diagnostic workup to assess existing lung damage (only 6% of patients have entirely normal HRCT images) and repeated every five years</p>
          </list-item>
          <list-item>
            <p>Thoracic computed tomography is the recommendation in patients with lung volume and pulmonary function abnormalities, or when the chest radiography demands further identification</p>
          </list-item>
          <list-item>
            <p>Lung magnetic resonance Imaging is viable as a radiation-sparing alternative</p>
          </list-item>
          <list-item>
            <p>Bronchoscopy and bronchoalveolar lavage are recommended&#x000a0; procedures in the case of suspected pulmonary granulomas</p>
          </list-item>
        </list>
        <p>
<bold>Lymphoproliferation</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Sonography, CT, or magnetic resonance (MR) of the abdomen (on-demand and in case of suspected lymphoma)</p>
          </list-item>
          <list-item>
            <p>Lymph node biopsy (on-demand and in case of suspected lymphoma)</p>
          </list-item>
        </list>
        <p>
<bold>Gastrointestinal Tract</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Upper endoscopy with biopsy to search for <italic toggle="yes">Helicobacter pylori</italic> infection (in case of clinical symptoms and every 24 months in case of increased risk for developing intestinal malignancy, as the general population)</p>
          </list-item>
          <list-item>
            <p>Lower endoscopy (on-demand)</p>
          </list-item>
        </list>
        <p>
<bold>Central Nervous System</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Magnetic resonance, cerebrospinal fluid analysis in case of neurological symptoms, especially infectious ones (on-demand).</p>
          </list-item>
        </list>
        <p>Generally, there are no uncommon findings in routine laboratories. Serum IgG should be below the normal limits and normally under 400mg/dL. Also, IgM and/or IgA should be below the normal limits.</p>
        <p>The patient&#x02019;s response to vaccines based on protein (IgG antibodies to tetanus and diphtheria) and polysaccharide (IgG antibodies to serotypes of the polysaccharides in the pneumococcal vaccine) requires assessment unless the antibody levels are deficient.</p>
        <p>Flow cytometry can be used to determine levels of circulating memory B cells, and levels of isotype switched memory B cells (as mentioned before).<xref ref-type="bibr" rid="article-19760.r46">[46]</xref><xref ref-type="bibr" rid="article-19760.r21">[21]</xref> On the other hand, molecular analysis is not required for the diagnosis of CVID but might be an option if there are other affected family members.<xref ref-type="bibr" rid="article-19760.r47">[47]</xref></p>
        <p>Biopsies are frequently done to discard malignancy or autoimmunity in the case of gastrointestinal disorders, pulmonary nodules, and dermatologic findings.</p>
      </sec>
      <sec id="article-19760.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>1. Immunoglobulin replacement</bold>
</p>
        <p>The mainstay of treatment is immunoglobulin replacement for those patients who have substantial impairments in its production (generally two standard deviations below the normal range for IgG) and a lack of response to protein and polysaccharide vaccines. Despite the high cost, immunoglobulin replacement can decrease the burden of recurrent infections and their complications.<xref ref-type="bibr" rid="article-19760.r48">[48]</xref> For patients who have higher levels of IgG and slight impairment in vaccine response, the clinician can postpone therapy but should follow the patient closely.</p>
        <p>Generally, after treating an active infection, therapy begins with adequate hydration. Subsequently, a slow infusion load of intravenous immune globulin (IVIG) must be administered until tolerance is appropriate, followed by maintenance doses.</p>
        <p>In patients prone to reactions, diphenhydramine and acetaminophen (and sometimes hydrocortisone) can be premedication. The subcutaneous route is an optional alternative in maintenance therapy (normally, weekly, or every other week). The initial dose for IVIG is 300 to 600 mg/kg every three to four weeks.</p>
        <p>The monitoring of IgG levels should take place every six months. Therefore, dosing adjustments may occur according to the patient's weight and IgG production.<xref ref-type="bibr" rid="article-19760.r49">[49]</xref></p>
        <p>
<bold>Adverse Reactions:</bold>
</p>
        <p>Intravenous immune globulin adverse reactions can be seen in 20 to 50% of patients, most likely during the first infusion, but they depend on the dose, infusion rate, organ dysfunction, prothrombotic stimuli, and brand.</p>
        <p>Subcutaneous immune globulin systemic adverse reactions are much lower than the first ones. Local reactions, such as pain and swelling are the most frequent ones.</p>
        <list list-type="bullet">
          <list-item>
            <p>Inflammatory reactions can occur during IVIG administration. The management is generally symptomatic.</p>
          </list-item>
          <list-item>
            <p>Anaphylaxis is rare but may be life-threatening. The treatment basis is on common protocols (securing the airway, administration of epinephrine, oxygen, salbutamol, antihistamine agents, and glucocorticoids).</p>
          </list-item>
          <list-item>
            <p>Thromboembolic risk events (as myocardial infarction, stroke, and venous thromboembolism) can be diminished by adequate hydration, avoiding prolonged immobilization, spacing larger doses, slowing infusions.</p>
          </list-item>
          <list-item>
            <p>Headache is common and treatable with normal painkillers.</p>
          </list-item>
          <list-item>
            <p>Acute kidney injury risk can be minimized with adequate hydration and avoiding concentrated or sucrose-containing products in those with existing renal disease.</p>
          </list-item>
          <list-item>
            <p>Hemolytic anemia can occur due to passive antibodies in the IVIG product. Reactions can vary from a positive direct Coombs test, mild extravascular hemolysis, and infrequently, intravascular hemolysis.</p>
          </list-item>
          <list-item>
            <p>Neutropenia can occur but is normally mild and transient.</p>
          </list-item>
        </list>
        <p>
<bold>2. Infections and antimicrobials</bold>
</p>
        <p>Generally, active bacterial infections are treated with longer courses of antibiotics (sometimes 2 or 3 times longer).</p>
        <p>Sputum examination or bronchoalveolar lavage is mandatory in all patients with sinopulmonary infections before antibiotic treatment.</p>
        <p>Prophylactic antimicrobials are not a routine recommendation. However, exacerbation of sinopulmonary infections could be less frequent with the administration of 250 mg of azithromycin three times weekly in susceptible individuals who receive replacement therapy.<xref ref-type="bibr" rid="article-19760.r50">[50]</xref></p>
        <p>High-risk immunodeficient patients should be considered during seasonal influenza. Prophylactic treatment may include antiviral therapy.</p>
        <p>
<bold>3.&#x000a0;</bold>
<bold>Autoimmune disorders</bold>
</p>
        <p>Glucocorticoids are the first-line treatment for immune thrombocytopenia and autoimmune hemolytic anemia. Higher doses are deliverable in patients that are currently on immune globulin replacement therapy.<xref ref-type="bibr" rid="article-19760.r36">[36]</xref> In glucocorticoid-refractory cases, rituximab should be considered,<xref ref-type="bibr" rid="article-19760.r51">[51]</xref> maintaining immune globulin replacement therapy; however, in severe refractory cases, splenectomy is the last option.<xref ref-type="bibr" rid="article-19760.r52">[52]</xref></p>
        <p>Treatment for rheumatologic diseases is the same as for patients who are not immunocompromised, along with the addition of immunoglobulin replacement.</p>
        <p>
<bold>4. Malignancies</bold>
</p>
        <p>Treatment for malignancies has as its basis for general population protocols.</p>
        <p>Unfortunately, there are no standardized monitoring protocols for cancer risk in these patients, therefore current recommendations of screening procedures must be age-appropriate, according to each country&#x02019;s guidelines.<xref ref-type="bibr" rid="article-19760.r53">[53]</xref><xref ref-type="bibr" rid="article-19760.r48">[48]</xref> However, all patients must be tested for Helicobacter pylori infection and pernicious anemia laboratory features, because of their relation to gastric malignancy.<xref ref-type="bibr" rid="article-19760.r39">[39]</xref></p>
        <p>
<bold>5. Vaccinations</bold>
</p>
        <p>Recommendations for vaccination is based on the antibody deficiency severity<xref ref-type="bibr" rid="article-19760.r54">[54]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Routine schedule for inactivated or subunit vaccines in mild deficiency:
<list list-type="bullet"><list-item><p>DTaP (diphtheria, tetanus toxoid, acellular pertussis vaccine)</p></list-item><list-item><p>HAV (Hepatitis A virus)</p></list-item><list-item><p>HBV (hepatitis B virus)</p></list-item><list-item><p>HIB (Haemophilus influenzae type B)</p></list-item><list-item><p>HPV (human papillomavirus)</p></list-item><list-item><p>Influenza</p></list-item><list-item><p>Meningococcal</p></list-item><list-item><p>Pneumococcal</p></list-item><list-item><p>Polio (intramuscular)</p></list-item><list-item><p>Anthrax</p></list-item><list-item><p>JE (Japanese encephalitis)</p></list-item><list-item><p>Typhoid (intramuscular).</p></list-item><list-item><p>Rabies</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Routine schedule for inactivated or subunit vaccines in severe deficiency:
<list list-type="bullet"><list-item><p>HPV</p></list-item><list-item><p>Influenza</p></list-item><list-item><p>Anthrax</p></list-item><list-item><p>Rabies</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Recommended administration of live-attenuated vaccines in mild deficiency (likely benefit but possible harm):
<list list-type="bullet"><list-item><p>MMR (measles-mumps-rubella)</p></list-item><list-item><p>Rotavirus</p></list-item><list-item><p>Varicella</p></list-item><list-item><p>Herpes Zoster</p></list-item><list-item><p>Smallpox (for pre-exposure)</p></list-item><list-item><p>BCG (Bacille Calmette-Guerin)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Live-attenuated vaccines are not recommended in severe deficiency.</p>
          </list-item>
        </list>
        <p>
<bold>6. Other recommendations</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Pulmonary diseases should be treated individually since there are no specific indications in CVID patients.</p>
          </list-item>
          <list-item>
            <p>Patients should no be given blood or blood components without testing for <italic toggle="yes">Cytomegalovirus</italic>.</p>
          </list-item>
          <list-item>
            <p>Regular dental care is mandatory. Prophylactic antibiotics are crucial before invasive dental procedures.</p>
          </list-item>
          <list-item>
            <p>Mental health following is crucial because patients are sometimes disintegrated from normal life activities.</p>
          </list-item>
          <list-item>
            <p>Audition care is essential given the fact that sensorineural loss frequently occurs probably because of recurrent bacterial otitis media, viral infections, periodic use of ototoxic antibiotics, and central nervous system infections.<xref ref-type="bibr" rid="article-19760.r55">[55]</xref></p>
          </list-item>
          <list-item>
            <p>The patient's parents must receive genetic counseling about the possibility of future children with the same disease.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19760.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The basis for differential diagnosis is on the main laboratory characteristic of CVID: hypogammaglobulinemia.</p>
        <p>Hypogammaglobulinemia can be primary or secondary. The primary causes are more common in children.</p>
        <list list-type="bullet">
          <list-item>
            <p>Secondary hypogammaglobulinemia can be due to decreased production (drugs, disorders that cause bone marrow suppression, Goodpasture syndrome, malignancy) or increased loss (protein-losing disorders such as enteropathies, nephrotic syndrome, burns).</p>
          </list-item>
          <list-item>
            <p>Primary hypogammaglobulinemia can be due to deficiency in IgG1 and IgG2, hyper-immunoglobulin M syndromes, and other combined immunodeficiencies.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19760.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The basis of medical complications and mortality statistics is from the largest series of 473 patients, followed over 40 years in New York.<xref ref-type="bibr" rid="article-19760.r4">[4]</xref></p>
        <p>Prognosis&#x000a0;in these patients is determined by the existence of pulmonary complications (respiratory failure due to chronic pulmonary disease) and malignancy (especially lymphoid), in which the appropriate and early therapy can prevent or slow down their development.<xref ref-type="bibr" rid="article-19760.r56">[56]</xref><xref ref-type="bibr" rid="article-19760.r57">[57]</xref></p>
        <p>Non-infectious complications have a prevalence of around 60 to 70%, and the risk of death because of them is 11 times higher.</p>
        <p>Deaths due to bacterial infection have been reduced dramatically with the rise of immune globulin therapy.<xref ref-type="bibr" rid="article-19760.r4">[4]</xref><xref ref-type="bibr" rid="article-19760.r30">[30]</xref> The risk of death is 95% lower among patients with only infectious complications.</p>
        <p>Overall mortality in CVID patients, according to age and sex-matched population controls, is around 20%.</p>
        <p>Malignant cells in these patients do not show greater resistance to standard protocols of treatment, but are more likely to widespread and, therefore, determine the need for a more aggressive therapy, which could bring poorly tolerated adverse effects.<xref ref-type="bibr" rid="article-19760.r58">[58]</xref></p>
        <p>On the other hand, the lower amounts of serum immunoglobulin G (IgG) and circulating class-switched memory B cells, and increased amount of serum immunoglobulin M (IgM) can be used to predict the risk for mortality because of a higher prevalence of autoimmune disease, granuloma formation, recurrent bacterial pneumonia, and lymphoid hyperplasia.</p>
        <p>It is unclear to what range IgG replacement could prevent complications.<xref ref-type="bibr" rid="article-19760.r59">[59]</xref></p>
      </sec>
      <sec id="article-19760.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of CVID are sometimes the clinical presentation onset of CVID patients. However, early-diagnosed and early-treated patients can develop complications in the future, which could shorten their life expectancy.</p>
        <p>The most frequent complications are associated with pulmonary disease. Therefore most patients with respiratory symptoms must be initially evaluated through HRCT.</p>
        <p>Pulmonary complications by descending order of frequency are<xref ref-type="bibr" rid="article-19760.r60">[60]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Bronchiectasis (approximately 20% of patients)<xref ref-type="bibr" rid="article-19760.r56">[56]</xref>: a common pathologic response to recurrent bacterial infections and/or lower airway inflammation.</p>
          </list-item>
          <list-item>
            <p>Bronchospasm</p>
          </list-item>
          <list-item>
            <p>Obstructive and restrictive pulmonary disease</p>
          </list-item>
          <list-item>
            <p>Granulomas</p>
          </list-item>
        </list>
        <p>The overall risk for developing cancer is estimated to range from 4% to 25%, and estimates of the incidence of malignancy are at around 10%, with a higher risk in adult-diagnosed CVID.<xref ref-type="bibr" rid="article-19760.r61">[61]</xref> The most frequent malignancies are described in order of frequency<xref ref-type="bibr" rid="article-19760.r30">[30]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Non-Hodgkin lymphoma: mostly with an extranodal origin (patients could have a lifetime risk of possibly 2% to 8%), and more likely in females over 30 years.<xref ref-type="bibr" rid="article-19760.r1">[1]</xref><xref ref-type="bibr" rid="article-19760.r4">[4]</xref> B cell is the most common type as expected, and they are usually well differentiated.</p>
          </list-item>
          <list-item>
            <p>Gastric carcinoma: associated with <italic toggle="yes">Helicobacter pylori</italic> infection and gastritis (incidence of less than 1%). Diagnosed in individuals younger than the overall gastric cancer population. Generally, it consists of a moderately to poorly differentiated intestinal-type adenocarcinoma with a high count of intra-tumoral lymphocytes.<xref ref-type="bibr" rid="article-19760.r62">[62]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19760.s12" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>Delayed recognition of this disease is common.</p>
          </list-item>
          <list-item>
            <p>CVID may result from various gene defects.</p>
          </list-item>
          <list-item>
            <p>Opportunistic infections are rare but can occur.</p>
          </list-item>
          <list-item>
            <p>Several causes of hypogammaglobulinemia have to be excluded before determining the diagnosis of CVID.</p>
          </list-item>
          <list-item>
            <p>Higher doses of immune globulin are recommended for those patients with persistent infections.</p>
          </list-item>
          <list-item>
            <p>There is not much evidence of immune globulin therapy and its protection against malignancy. However, evidence shows that treatment can reduce the progression of pulmonary disease and the frequency of several infections. Also, it may offer protection against autoimmunity.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19760.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Patients with CVID require an integrated interprofessional team approach to improve short-term and long-term patient outcomes. They need frequent specialized clinical provider evaluations, including an infectious disease specialist and immunologist. A dedicated nurse can assess and educate the patient as well as his family about potential complications and symptoms to monitor. A specialized pharmacist is required to ensure proper dosing of IVIG as well as appropriate dosing and duration of antibiotics for infection episodes. Above all, the clinical provider, the nursing staff, as well as the clinical pharmacist, need to provide an integrated interprofessional approach to patient education to minimize complications of the disease and to improve patient outcomes. Preventive care with appropriate vaccination (avoiding live vaccines such as oral polio, smallpox, influenza, yellow fever, oral typhoid), dental, auditive, and mental care requires attention, as mentioned previously. Close communication between the team members is vital to ensure good outcomes. [Level 5]</p>
      </sec>
      <sec id="article-19760.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19760&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19760">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/common-variable-immunodeficiency-immune-deficiency-due-to-low-levels-of-antibodies/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=19760">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19760/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19760">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-19760.s15">
        <title>References</title>
        <ref id="article-19760.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bodian</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Common variable immunodeficiency: clinical and immunological features of 248 patients.</article-title>
            <source>Clin Immunol</source>
            <year>1999</year>
            <month>Jul</month>
            <volume>92</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <page-range>34-48</page-range>
            <pub-id pub-id-type="pmid">10413651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonilla</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Barlan</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Chapel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Costa-Carvalho</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>de la Morena</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Espinosa-Rosales</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Hammarstr&#x000f6;m</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nonoyama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Quinti</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Routes</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Warnatz</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.</article-title>
            <source>J Allergy Clin Immunol Pract</source>
            <year>2016</year>
            <season>Jan-Feb</season>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>38</fpage>
            <page-range>38-59</page-range>
            <pub-id pub-id-type="pmid">26563668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chapel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions.</article-title>
            <source>Br J Haematol</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>145</volume>
            <issue>6</issue>
            <fpage>709</fpage>
            <page-range>709-27</page-range>
            <pub-id pub-id-type="pmid">19344423</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Resnick</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Moshier</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Godbold</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Morbidity and mortality in common variable immune deficiency over 4 decades.</article-title>
            <source>Blood</source>
            <year>2012</year>
            <month>Feb</month>
            <day>16</day>
            <volume>119</volume>
            <issue>7</issue>
            <fpage>1650</fpage>
            <page-range>1650-7</page-range>
            <pub-id pub-id-type="pmid">22180439</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Herz</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bousfiha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Casanova</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Chapel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Conley</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Etzioni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Franco</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Geha</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Hammarstr&#x000f6;m</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nonoyama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Notarangelo</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Ochs</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Puck</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Roifman</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Seger</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency.</article-title>
            <source>Front Immunol</source>
            <year>2011</year>
            <volume>2</volume>
            <fpage>54</fpage>
            <pub-id pub-id-type="pmid">22566844</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Herz</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bousfiha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Casanova</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Chatila</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Conley</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Etzioni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Franco</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Gaspar</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nonoyama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ochs</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Oksenhendler</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Picard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Puck</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency.</article-title>
            <source>Front Immunol</source>
            <year>2014</year>
            <volume>5</volume>
            <fpage>162</fpage>
            <pub-id pub-id-type="pmid">24795713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bogaert</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Dullaers</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lambrecht</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Vermaelen</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>De Baere</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Haerynck</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Genes associated with common variable immunodeficiency: one diagnosis to rule them all?</article-title>
            <source>J Med Genet</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>53</volume>
            <issue>9</issue>
            <fpage>575</fpage>
            <page-range>575-90</page-range>
            <pub-id pub-id-type="pmid">27250108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chapel</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Common Variable Immunodeficiency Disorders (CVID) - Diagnoses of Exclusion, Especially Combined Immune Defects.</article-title>
            <source>J Allergy Clin Immunol Pract</source>
            <year>2016</year>
            <season>Nov-Dec</season>
            <volume>4</volume>
            <issue>6</issue>
            <fpage>1158</fpage>
            <page-range>1158-1159</page-range>
            <pub-id pub-id-type="pmid">27836061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nijenhuis</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Klasen</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Weemaes</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Preijers</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>de Vries</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>van der Meer</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Common variable immunodeficiency (CVID) in a family: an autosomal dominant mode of inheritance.</article-title>
            <source>Neth J Med</source>
            <year>2001</year>
            <month>Sep</month>
            <volume>59</volume>
            <issue>3</issue>
            <fpage>134</fpage>
            <page-range>134-9</page-range>
            <pub-id pub-id-type="pmid">11583829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hammarstr&#x000f6;m</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vorechovsky</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Webster</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID).</article-title>
            <source>Clin Exp Immunol</source>
            <year>2000</year>
            <month>May</month>
            <volume>120</volume>
            <issue>2</issue>
            <fpage>225</fpage>
            <page-range>225-31</page-range>
            <pub-id pub-id-type="pmid">10792368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oksenhendler</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>G&#x000e9;rard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fieschi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Malphettes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mouillot</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Jaussaud</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Viallard</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Gardembas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Galicier</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schleinitz</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Suarez</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Soulas-Sprauel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hachulla</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jaccard</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gardeur</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Th&#x000e9;odorou</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rabian</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Debr&#x000e9;</surname>
                <given-names>P</given-names>
              </name>
              <collab>DEFI Study Group</collab>
            </person-group>
            <article-title>Infections in 252 patients with common variable immunodeficiency.</article-title>
            <source>Clin Infect Dis</source>
            <year>2008</year>
            <month>May</month>
            <day>15</day>
            <volume>46</volume>
            <issue>10</issue>
            <fpage>1547</fpage>
            <page-range>1547-54</page-range>
            <pub-id pub-id-type="pmid">18419489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rezaei</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wing</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Aghamohammadi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carlring</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lees</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Asgarian-Omran</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pourpak</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Sarrafnejad</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kardar</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Shahrestani</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Masoumi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zare</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saghafi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sarrafzadeh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Heath</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Read</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>B-cell-T-cell activation and interaction in common variable immunodeficiency.</article-title>
            <source>Hum Immunol</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>71</volume>
            <issue>4</issue>
            <fpage>355</fpage>
            <page-range>355-62</page-range>
            <pub-id pub-id-type="pmid">20097245</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roskin</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Simchoni</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hoh</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Pham</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Furman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dekker</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Nadeau</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Boyd</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>IgH sequences in common variable immune deficiency reveal altered B cell development and selection.</article-title>
            <source>Sci Transl Med</source>
            <year>2015</year>
            <month>Aug</month>
            <day>26</day>
            <volume>7</volume>
            <issue>302</issue>
            <fpage>302ra135</fpage>
            <pub-id pub-id-type="pmid">26311730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Radigan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nakazawa</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>TLR9 activation is defective in common variable immune deficiency.</article-title>
            <source>J Immunol</source>
            <year>2006</year>
            <month>Feb</month>
            <day>01</day>
            <volume>176</volume>
            <issue>3</issue>
            <fpage>1978</fpage>
            <page-range>1978-87</page-range>
            <pub-id pub-id-type="pmid">16424230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Radigan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Marron</surname>
                <given-names>TU</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sanchez-Ram&#x000f3;n</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Toll-like receptor 7 and 9 defects in common variable immunodeficiency.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>124</volume>
            <issue>2</issue>
            <fpage>349</fpage>
            <page-range>349-56, 356.e1-3</page-range>
            <pub-id pub-id-type="pmid">19592080</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bernasconi</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Traggiai</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lanzavecchia</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Maintenance of serological memory by polyclonal activation of human memory B cells.</article-title>
            <source>Science</source>
            <year>2002</year>
            <month>Dec</month>
            <day>13</day>
            <volume>298</volume>
            <issue>5601</issue>
            <fpage>2199</fpage>
            <page-range>2199-202</page-range>
            <pub-id pub-id-type="pmid">12481138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Escobar</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pons</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Clemente</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Iglesias</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Regueiro</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bengoechea</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Matamoros</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ferrer</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Defective B cell response to TLR9 ligand (CpG-ODN), Streptococcus pneumoniae and Haemophilus influenzae extracts in common variable immunodeficiency patients.</article-title>
            <source>Cell Immunol</source>
            <year>2010</year>
            <volume>262</volume>
            <issue>2</issue>
            <fpage>105</fpage>
            <page-range>105-11</page-range>
            <pub-id pub-id-type="pmid">20171611</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ochtrop</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Goldacker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>May</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Rizzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Draeger</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hauschke</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Stehfest</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Warnatz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Goebel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Technau-Ihling</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Werner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Salzer</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Eibel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schlesier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Peter</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>T and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency.</article-title>
            <source>Blood</source>
            <year>2011</year>
            <month>Jul</month>
            <day>14</day>
            <volume>118</volume>
            <issue>2</issue>
            <fpage>309</fpage>
            <page-range>309-18</page-range>
            <pub-id pub-id-type="pmid">21576700</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Warnatz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Denz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dr&#x000e4;ger</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Braun</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Groth</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wolff-Vorbeck</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Eibel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schlesier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Peter</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease.</article-title>
            <source>Blood</source>
            <year>2002</year>
            <month>Mar</month>
            <day>01</day>
            <volume>99</volume>
            <issue>5</issue>
            <fpage>1544</fpage>
            <page-range>1544-51</page-range>
            <pub-id pub-id-type="pmid">11861266</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piqueras</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lavenu-Bombled</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Galicier</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bergeron-van der Cruyssen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mouthon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chevret</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Debr&#x000e9;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schmitt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Oksenhendler</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects.</article-title>
            <source>J Clin Immunol</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>385</fpage>
            <page-range>385-400</page-range>
            <pub-id pub-id-type="pmid">14601647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wehr</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kivioja</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schmitt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ferry</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Witte</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Eren</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vlkova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hernandez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Detkova</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bos</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Poerksen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>von Bernuth</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Baumann</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Goldacker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gutenberger</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schlesier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bergeron-van der Cruyssen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Le Garff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Debr&#x000e9;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bateman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Litzman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van Hagen</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Plebani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Thon</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Quinti</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Espanol</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Webster</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Chapel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Vihinen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oksenhendler</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Peter</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Warnatz</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The EUROclass trial: defining subgroups in common variable immunodeficiency.</article-title>
            <source>Blood</source>
            <year>2008</year>
            <month>Jan</month>
            <day>01</day>
            <volume>111</volume>
            <issue>1</issue>
            <fpage>77</fpage>
            <page-range>77-85</page-range>
            <pub-id pub-id-type="pmid">17898316</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>S&#x000e1;nchez-Ram&#x000f3;n</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Radigan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Bard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Memory B cells in common variable immunodeficiency: clinical associations and sex differences.</article-title>
            <source>Clin Immunol</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>128</volume>
            <issue>3</issue>
            <fpage>314</fpage>
            <page-range>314-21</page-range>
            <pub-id pub-id-type="pmid">18620909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carsetti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rosado</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Donnanno</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guazzi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Soresina</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Meini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Plebani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aiuti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Quinti</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>115</volume>
            <issue>2</issue>
            <fpage>412</fpage>
            <page-range>412-7</page-range>
            <pub-id pub-id-type="pmid">15696104</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ballegaard</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Permin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Katzenstein</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Marquart</surname>
                <given-names>HV</given-names>
              </name>
              <name>
                <surname>Schejbel</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Long-term follow-up on affinity maturation and memory B-cell generation in patients with common variable immunodeficiency.</article-title>
            <source>J Clin Immunol</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>1067</fpage>
            <page-range>1067-77</page-range>
            <pub-id pub-id-type="pmid">23649616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Manguiat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Berglund</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Knerr</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tahami</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Grimbacher</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fulcher</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiency.</article-title>
            <source>Clin Exp Immunol</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>156</volume>
            <issue>3</issue>
            <fpage>446</fpage>
            <page-range>446-54</page-range>
            <pub-id pub-id-type="pmid">19438597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Serana</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Air&#x000f2;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chiarini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zanotti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Scarsi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Frassi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lougaris</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Plebani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Caimi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Imberti</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Thymic and bone marrow output in patients with common variable immunodeficiency.</article-title>
            <source>J Clin Immunol</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>540</fpage>
            <page-range>540-9</page-range>
            <pub-id pub-id-type="pmid">21491094</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malphettes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>G&#x000e9;rard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Carmagnat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mouillot</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vince</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Boutboul</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>B&#x000e9;rezn&#x000e9;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nove-Josserand</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lemoing</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tetu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Viallard</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Bonnotte</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pavic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Haroche</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Larroche</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brouet</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Fermand</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Rabian</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fieschi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Oksenhendler</surname>
                <given-names>E</given-names>
              </name>
              <collab>DEFI Study Group</collab>
            </person-group>
            <article-title>Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect.</article-title>
            <source>Clin Infect Dis</source>
            <year>2009</year>
            <month>Nov</month>
            <day>01</day>
            <volume>49</volume>
            <issue>9</issue>
            <fpage>1329</fpage>
            <page-range>1329-38</page-range>
            <pub-id pub-id-type="pmid">19807277</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahmoudi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hedayat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aghamohammadi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rezaei</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Soluble CD26 and CD30 levels in patients with common variable immunodeficiency.</article-title>
            <source>J Investig Allergol Clin Immunol</source>
            <year>2013</year>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>120</fpage>
            <page-range>120-4</page-range>
            <pub-id pub-id-type="pmid">23654079</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Radigan</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Deficient IL-12 and dendritic cell function in common variable immune deficiency.</article-title>
            <source>Clin Immunol</source>
            <year>2005</year>
            <month>May</month>
            <volume>115</volume>
            <issue>2</issue>
            <fpage>147</fpage>
            <page-range>147-53</page-range>
            <pub-id pub-id-type="pmid">15885637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chapel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lucas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bjorkander</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Webster</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Grimbacher</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fieschi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thon</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Abedi</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Hammarstrom</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Common variable immunodeficiency disorders: division into distinct clinical phenotypes.</article-title>
            <source>Blood</source>
            <year>2008</year>
            <month>Jul</month>
            <day>15</day>
            <volume>112</volume>
            <issue>2</issue>
            <fpage>277</fpage>
            <page-range>277-86</page-range>
            <pub-id pub-id-type="pmid">18319398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Busse</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Farzan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary complications of common variable immunodeficiency.</article-title>
            <source>Ann Allergy Asthma Immunol</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>98</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-8; quiz 8-11, 43</page-range>
            <pub-id pub-id-type="pmid">17225714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kainulainen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Suonp&#x000e4;&#x000e4;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nikoskelainen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Svedstr&#x000f6;m</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vuorinen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Meurman</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Ruuskanen</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Bacteria and viruses in maxillary sinuses of patients with primary hypogammaglobulinemia.</article-title>
            <source>Arch Otolaryngol Head Neck Surg</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>133</volume>
            <issue>6</issue>
            <fpage>597</fpage>
            <page-range>597-602</page-range>
            <pub-id pub-id-type="pmid">17576911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cadranel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bouvry</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wislez</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Respiratory manifestations of common variable immunodeficiency in adults].</article-title>
            <source>Rev Mal Respir</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>20</volume>
            <issue>1 Pt 1</issue>
            <fpage>126</fpage>
            <page-range>126-33</page-range>
            <pub-id pub-id-type="pmid">12709641</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aghamohammadi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Allahverdi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abolhassani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Moazzami</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Alizadeh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gharagozlou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kalantari</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sajedi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Shafiei</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Parvaneh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mohammadpour</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Karimi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sadaghiani</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Rezaei</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia.</article-title>
            <source>Respirology</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>289</fpage>
            <page-range>289-95</page-range>
            <pub-id pub-id-type="pmid">20051045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agarwal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>124</volume>
            <issue>4</issue>
            <fpage>658</fpage>
            <page-range>658-64</page-range>
            <pub-id pub-id-type="pmid">19665769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID).</article-title>
            <source>J Autoimmun</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-62</page-range>
            <pub-id pub-id-type="pmid">15994061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Swierkot</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lewandowicz-Uszynska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chlebicki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Szmyrka-Kaczmarek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pola&#x00144;ska</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jankowski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Szechinski</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Rheumatoid arthritis in a patient with common variable immunodeficiency: difficulty in diagnosis and therapy.</article-title>
            <source>Clin Rheumatol</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>92</fpage>
            <page-range>92-4</page-range>
            <pub-id pub-id-type="pmid">15940551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fern&#x000e1;ndez-Castro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mellor-Pita</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Citores</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tutor-Ureta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vargas</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Yebra-Bango</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Andreu</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Common variable immunodeficiency in systemic lupus erythematosus.</article-title>
            <source>Semin Arthritis Rheum</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>238</fpage>
            <page-range>238-45</page-range>
            <pub-id pub-id-type="pmid">17276173</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dhalla</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>da Silva</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Lucas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Travis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chapel</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme.</article-title>
            <source>Clin Exp Immunol</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>165</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-7</page-range>
            <pub-id pub-id-type="pmid">21470209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pagnini</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Simonini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lippi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Azzari</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cimaz</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous polyarteritis nodosa and common variable immunodeficiency: a previously unreported association.</article-title>
            <source>Clin Exp Rheumatol</source>
            <year>2012</year>
            <season>Jan-Feb</season>
            <volume>30</volume>
            <issue>1 Suppl 70</issue>
            <fpage>S169</fpage>
            <pub-id pub-id-type="pmid">22260879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Urschel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kayikci</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wintergerst</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Notheis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Jansson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Belohradsky</surname>
                <given-names>BH</given-names>
              </name>
            </person-group>
            <article-title>Common variable immunodeficiency disorders in children: delayed diagnosis despite typical clinical presentation.</article-title>
            <source>J Pediatr</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>154</volume>
            <issue>6</issue>
            <fpage>888</fpage>
            <page-range>888-94</page-range>
            <pub-id pub-id-type="pmid">19230900</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salzer</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Warnatz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Peter</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Common variable immunodeficiency: an update.</article-title>
            <source>Arthritis Res Ther</source>
            <year>2012</year>
            <month>Sep</month>
            <day>24</day>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>223</fpage>
            <pub-id pub-id-type="pmid">23043756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rich</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Le Jeune</surname>
                <given-names>IR</given-names>
              </name>
              <name>
                <surname>McDermott</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kinnear</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Serial lung function tests in primary immune deficiency.</article-title>
            <source>Clin Exp Immunol</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>151</volume>
            <issue>1</issue>
            <fpage>110</fpage>
            <page-range>110-3</page-range>
            <pub-id pub-id-type="pmid">18005259</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stafler</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Non-cystic fibrosis bronchiectasis: its diagnosis and management.</article-title>
            <source>Arch Dis Child Educ Pract Ed</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>95</volume>
            <issue>3</issue>
            <fpage>73</fpage>
            <page-range>73-82</page-range>
            <pub-id pub-id-type="pmid">20501530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cinetto</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Scarpa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rattazzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Agostini</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The broad spectrum of lung diseases in primary antibody deficiencies.</article-title>
            <source>Eur Respir Rev</source>
            <year>2018</year>
            <month>Sep</month>
            <day>30</day>
            <volume>27</volume>
            <issue>149</issue>
            <pub-id pub-id-type="pmid">30158276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quinti</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Soresina</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spadaro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Martino</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Donnanno</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Agostini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Claudio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Franco</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Maria Pesce</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Borghese</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Guerra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rondelli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Plebani</surname>
                <given-names>A</given-names>
              </name>
              <collab>Italian Primary Immunodeficiency Network</collab>
            </person-group>
            <article-title>Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency.</article-title>
            <source>J Clin Immunol</source>
            <year>2007</year>
            <month>May</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>308</fpage>
            <page-range>308-16</page-range>
            <pub-id pub-id-type="pmid">17510807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Orange</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Glessner</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Resnick</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Lucas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferry</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Hou</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chiavacci</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kugathasan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sleasman</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Baldassano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Perez</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Chapel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hakonarson</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Genome-wide association identifies diverse causes of common variable immunodeficiency.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>127</volume>
            <issue>6</issue>
            <fpage>1360</fpage>
            <page-range>1360-7.e6</page-range>
            <pub-id pub-id-type="pmid">21497890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>How I treat common variable immune deficiency.</article-title>
            <source>Blood</source>
            <year>2010</year>
            <month>Jul</month>
            <day>08</day>
            <volume>116</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-15</page-range>
            <pub-id pub-id-type="pmid">20332369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lucas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lortan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lopez-Granados</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Misbah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chapel</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>125</volume>
            <issue>6</issue>
            <fpage>1354</fpage>
            <page-range>1354-1360.e4</page-range>
            <pub-id pub-id-type="pmid">20471071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Milito</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pulvirenti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cinetto</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lougaris</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Soresina</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pecoraro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vultaggio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carrabba</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lassandro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Plebani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spadaro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Matucci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fabio</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dellepiane</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Martire</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Agostini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Abeni</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tabolli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Quinti</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>144</volume>
            <issue>2</issue>
            <fpage>584</fpage>
            <page-range>584-593.e7</page-range>
            <pub-id pub-id-type="pmid">30910492</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gobert</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bussel</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Galicier</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dechartres</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Berezne</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bonnotte</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>DeRevel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Auzary</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jaussaud</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Larroche</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>LeQuellec</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ruivard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Seve</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Smail</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Viallard</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Godeau</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hermine</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Michel</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients.</article-title>
            <source>Br J Haematol</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>155</volume>
            <issue>4</issue>
            <fpage>498</fpage>
            <page-range>498-508</page-range>
            <pub-id pub-id-type="pmid">21981575</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>S&#x000e8;ve</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bourdillon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sarrot-Reynauld</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ruivard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jaussaud</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bouhour</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bonotte</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gardembas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Poindron</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Thiercelin</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Broussolle</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Oksenhendler</surname>
                <given-names>E</given-names>
              </name>
              <collab>DEF-I Study Group</collab>
            </person-group>
            <article-title>Autoimmune hemolytic anemia and common variable immunodeficiency: a case-control study of 18 patients.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2008</year>
            <month>May</month>
            <volume>87</volume>
            <issue>3</issue>
            <fpage>177</fpage>
            <page-range>177-184</page-range>
            <pub-id pub-id-type="pmid">18520327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van der Poorten</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ahlenstiel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Read</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kwok</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Santhakumar</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bassan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Culican</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>SWJ</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jideh</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kane</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Katelaris</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Keat</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ko</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Limaye</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Murad</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rafferty</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Suan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Swaminathan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Riminton</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Toong</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Berglund</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Gastric Cancer Screening in Common Variable Immunodeficiency.</article-title>
            <source>J Clin Immunol</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>38</volume>
            <issue>7</issue>
            <fpage>768</fpage>
            <page-range>768-777</page-range>
            <pub-id pub-id-type="pmid">30219982</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sobh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bonilla</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>Vaccination in Primary Immunodeficiency Disorders.</article-title>
            <source>J Allergy Clin Immunol Pract</source>
            <year>2016</year>
            <season>Nov-Dec</season>
            <volume>4</volume>
            <issue>6</issue>
            <fpage>1066</fpage>
            <page-range>1066-1075</page-range>
            <pub-id pub-id-type="pmid">27836056</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berlucchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Soresina</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Redaelli De Zinis</surname>
                <given-names>LO</given-names>
              </name>
              <name>
                <surname>Valetti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Valotti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lougaris</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Meini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Salsi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nicolai</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Plebani</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Sensorineural hearing loss in primary antibody deficiency disorders.</article-title>
            <source>J Pediatr</source>
            <year>2008</year>
            <month>Aug</month>
            <volume>153</volume>
            <issue>2</issue>
            <fpage>293</fpage>
            <page-range>293-6</page-range>
            <pub-id pub-id-type="pmid">18639734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gathmann</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mahlaoui</surname>
                <given-names>N</given-names>
              </name>
              <collab>CEREDIH</collab>
              <name>
                <surname>G&#x000e9;rard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Oksenhendler</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Warnatz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schulze</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kindle</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kuijpers</surname>
                <given-names>TW</given-names>
              </name>
              <collab>Dutch WID</collab>
              <name>
                <surname>van Beem</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Guzman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Workman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Soler-Palac&#x000ed;n</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>De Gracia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Witte</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Litzman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hlavackova</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Thon</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Borte</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Borte</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kumararatne</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Feighery</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Longhurst</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Helbert</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Szaflarska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sediva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Belohradsky</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baumann</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Meyts</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kutukculer</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>W&#x000e5;gstr&#x000f6;m</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Galal</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Roesler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Farmaki</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zinovieva</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ciznar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Papadopoulou-Alataki</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bienemann</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Velbri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Panahloo</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Grimbacher</surname>
                <given-names>B</given-names>
              </name>
              <collab>European Society for Immunodeficiencies Registry Working Party</collab>
            </person-group>
            <article-title>Clinical picture and treatment of 2212 patients with common variable immunodeficiency.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>134</volume>
            <issue>1</issue>
            <fpage>116</fpage>
            <page-range>116-26</page-range>
            <pub-id pub-id-type="pmid">24582312</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Odnoletkova</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kindle</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Quinti</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Grimbacher</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Knerr</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gathmann</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ehl</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mahlaoui</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Van Wilder</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bogaerts</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>de Vries</surname>
                <given-names>E</given-names>
              </name>
              <collab>Plasma Protein Therapeutics Association (PPTA) Taskforce</collab>
            </person-group>
            <article-title>The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2018</year>
            <month>Nov</month>
            <day>12</day>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>201</fpage>
            <pub-id pub-id-type="pmid">30419968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shapiro</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Malignancies in the setting of primary immunodeficiency: Implications for hematologists/oncologists.</article-title>
            <source>Am J Hematol</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>86</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <page-range>48-55</page-range>
            <pub-id pub-id-type="pmid">21120868</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gregersen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aal&#x000f8;kken</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Mynarek</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fevang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Holm</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ueland</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Aukrust</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kongerud</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Johansen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fr&#x000f8;land</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors.</article-title>
            <source>Ann Allergy Asthma Immunol</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>104</volume>
            <issue>6</issue>
            <fpage>503</fpage>
            <page-range>503-10</page-range>
            <pub-id pub-id-type="pmid">20568383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Knight</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Inflammatory and autoimmune complications of common variable immune deficiency.</article-title>
            <source>Autoimmun Rev</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>156</fpage>
            <page-range>156-9</page-range>
            <pub-id pub-id-type="pmid">16431351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tak Manesh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Azizi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Heydari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kiaee</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Shaghaghi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hossein-Khannazer</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yazdani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Abolhassani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Aghamohammadi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and pathophysiology of malignancy in common variable immunodeficiency?</article-title>
            <source>Allergol Immunopathol (Madr)</source>
            <year>2017</year>
            <season>Nov-Dec</season>
            <volume>45</volume>
            <issue>6</issue>
            <fpage>602</fpage>
            <page-range>602-615</page-range>
            <pub-id pub-id-type="pmid">28411962</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19760.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leone</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vacca</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dammacco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Racanelli</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Common Variable Immunodeficiency and Gastric Malignancies.</article-title>
            <source>Int J Mol Sci</source>
            <year>2018</year>
            <month>Feb</month>
            <day>02</day>
            <volume>19</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">29393912</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
